Stay updated on Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedThe clinical-trial record for the napabucasin and FOLFIRI study is displayed with its study details, eligibility criteria, treatment arms, outcomes, locations, and study documents. The prior 403 error page and NIH transition notice are no longer shown.SummaryDifference100%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The study record is still showing a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedAn NIH-wide notice about website changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2; the study record still displays a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s site revision changes from v3.7.0 to v3.7.1, while the page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page for the study NCT02753127 on ClinicalTrials.gov now shows a 403 Forbidden error instead of the usual content. This indicates the record is currently inaccessible.SummaryDifference18%

- Check60 days agoChange DetectedA new revision tag, v3.7.0, was added and the previous tag v3.6.6 was removed. This reflects an update to the page version rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.